Cardiac effects of low-dose growth hormone replacement therapy in growth hormone-deficient adults: An 18-month randomised, placebo-controlled, double-blind study

Hormone Research

Volumn 58, Issue 1, 2002, Pages 21-29

  Bjerregård Sneppen, Simone ^a   Steensgaard Hansen, Frank ^a   Feldt Rasmussen, Ulla ^a  

^a University of Copenhagen   (Denmark)

Author keywords

Cardiac anatomy; Cardiac function; Growth hormone

Indexed keywords

GROWTH HORMONE; HYPOPHYSIS HORMONE; PLACEBO; HUMAN GROWTH HORMONE;

ADULT; ANATOMY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DRUG EFFECT; ECHOCARDIOGRAPHY; FEMALE; GROWTH HORMONE DEFICIENCY; HEART; HEART FUNCTION; HORMONE SUBSTITUTION; HUMAN; LONG TERM CARE; MALE; ONSET AGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; ADENOMA; CRANIOPHARYNGIOMA; CUSHING SYNDROME; DOUBLE BLIND PROCEDURE; HEART CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HISTOLOGY; HYPOPHYSIS TUMOR; MIDDLE AGED; MORTALITY; PHYSIOLOGY; PROLACTINOMA;

ADENOMA; ADULT; CRANIOPHARYNGIOMA; CUSHING SYNDROME; DOUBLE-BLIND METHOD; FEMALE; HEART; HUMAN; HUMAN GROWTH HORMONE; MALE; MIDDLE AGE; MYOCARDIAL CONTRACTION; PITUITARY NEOPLASMS; PROLACTINOMA; SUPPORT, NON-U.S. GOV'T; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; HUMANS; MIDDLE AGED;

EID: 0036059405     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000063212     Document Type: Article

References (38)

1. Premature mortality due to cardiovascular disease in hypopituitarism
2. Cardiovascular mortality among pituitary insufficient patients
3. Hypopituitary females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors
4. Association between premature mortality and hypopituitarism
5. Mortality in acromegaly
6. Cardiac failure responding to growth hormone
7. Reversible dilated cardiomyopathy due to growth hormone deficiency
8. Growth hormone and the heart
9. Body composition, bone metabolism and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses
10. Cardiac structure and functional abnormalities in adult patients with growth hormone deficiency
11. Impaired cardiac performance in GH-deficient adults and its improvement after GH replacement
12. Improved left ventricular function after growth hormone replacement in patients with hypopituitarism: Assessment with radionuclide angiography
13. Myocardial dysfunction in treated adult hypopituitarism: A possible explanation for increased cardiovascular mortality
14. Cardiac performance and mass in adults with hypopituitarism: Effects of one year of growth hormone treatment
15. Cardiovascular effects of growth hormone treatment in growth-hormone-deficient adults: Stimulation of the renin-aldosteron system
16. Long-term cardiovascular effects of growth hormone treatment in GH-deficient adults: Preliminary data in a small group of patients
17. Recommendations regarding quatitation in M-mode echocardiography: Results of a survey of echocardiographic measurements
18. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method
19. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
20. Clinical calorimetry: A formula to estimate the approximate surface area if height and weight be known
21. Cardiac performance after reduction of myocardial hypertrophy
22. Noninvasive determination of left ventricular end-systolic stress: Validation of the method and initial application
23. Assessment of diastolic function in normal and hypertrophied hearts: Comparison of Doppler echocardiography and M-mode echocardiography
24. Left ventricular diastolic parameters in 288 normal subjects from 20 to 80 years old
25. The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults
26. Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial
27. Effect of growth hormone (hGH) replacement therapy on physical work capacity and cardiac and pulmonary function in patients with hGH deficiency aquired in childhood
28. Cardiovascular effects of growth hormone replacement therapy in hypopituitary adults
29. The effects of low-dose recombinant human growth hormone on cardiovascular structure and function in hypopituitary growth hormone-deficient adults
30. Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency
31. Long-term effects of growth hormone (GH) replacement in men with childhood-onset GH deficiency
32. Short and long-term cardiovascular effects of growth hormone therapy in growth hormone deficient adults
33. Beneficial effects of growth hormone treatment in GH-deficient adults
34. Increased myocardial contractility following growth hormone administration in normal men. An echocardiographic study
35. Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984
36. Echocardiographic dimensions and function in adults with primary growth hormone resistance (Laron syndrome)
37. Echocardiographic evidence for a direct effect of GH/IGF-I hypersecretion on cardiac mass and function in young acromegalics
38. Left ventricular function in young adults with childhood and adulthood onset growth hormone deficiency